MS vs UNH: Which Is the Better Buy?
Side-by-side comparison of Morgan Stanley and UnitedHealth Group Incorporated — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-18.
Morgan Stanley · Financial Services
$206.27
+15.9% upside to fair value
Med Conviction
Grade C
VS
UnitedHealth Group Incorporated · Healthcare
$375.21
+28.2% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
UNH has more upside to fair value
(+28.2%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
MS |
UNH |
| Current Price |
$206.27 |
$375.21 |
| Fair Value Estimate |
$239.00 |
$481.06 |
| Upside to Fair Value |
+15.9%
|
+28.2%
|
| Market Cap |
$325.4B |
$340.7B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
23.5x
|
15.0x
|
| Price / Sales |
2.6x
|
0.8x
|
| Price / FCF |
—
|
14.4x
|
| Revenue Growth YoY |
+22.4%
|
+0.4%
|
| Gross Margin |
59.7%
|
22.5%
|
| Operating Margin |
20.7%
|
4.8%
|
| Return on Equity |
18.1%
|
14.6%
|
| Dividend Yield |
2.01% |
2.41% |
| FCF Yield |
—
|
6.95%
|
| Analyst Consensus |
Hold
|
Strong Buy
|
Investment Thesis
Morgan Stanley is a diversified capital-markets and wealth-management franchise spanning institutional securities, advisor-led and self-directed wealth, workplace services, and investment management. Business quality is solid but inherently cyclical: it combines $8.084 trillion of wealth client assets and $2.004 trillion of investment-management AUM/AUS with a strengthening 15.5% institutional pe…
UnitedHealth Group is the largest diversified healthcare enterprise in the United States, operating UnitedHealthcare insurance plans alongside Optum Health, Optum Insight, and Optum Rx, with 390,000 employees and a market capitalization of $340.74 billion. The business quality is high: a 14.6% return on equity, $26.07 in free cash flow per share, and a P/FCF of 14.39 demonstrate strong cash gener…
Accumulation Zones
| Metric |
MS |
UNH |
| Zone Low |
$179.25 |
$360.80 |
| Zone High |
$203.15 |
$408.90 |
| In Buy Zone? |
No
|
Yes
|